Details for New Drug Application (NDA): 020599
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in RILUTEK is riluzole. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the riluzole profile page.
Summary for 020599
Tradename: | RILUTEK |
Applicant: | Covis |
Ingredient: | riluzole |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 020599
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RILUTEK | riluzole | TABLET;ORAL | 020599 | NDA | Covis Pharma US, Inc | 70515-700 | 70515-700-60 | 1 BOTTLE in 1 CARTON (70515-700-60) / 60 TABLET in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Dec 12, 1995 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020599
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Covis | RILUTEK | riluzole | TABLET;ORAL | 020599-001 | Dec 12, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription